PDCD1 and cholangiocarcinoma: Pan-cancer analysis of CMTM6 protein expression showed that PD-L1 expression was positively correlated with CMTM6 expression in CCA, implying that high CMTM6 expression could respond better to anti-PD-1/PD-L1 immunotherapy [62].